August 7, 2020
Category: News Coverage
August 6, 2020
Elemental: The Unique Devastation of Cancer in a Pandemic
August 6, 2020
Targeted Oncology: Autologous CAR T-Cell Therapy Induces Durable Responses in Relapsed/Refractory Hodgkin Lymphoma
August 6, 2020
OncLive: CD30-Targeted CAR T-Cell Therapy Elicits Durable Responses in Relapsed/Refractory Hodgkin Lymphoma
August 5, 2020
HemOnc Today: Anti-CD30 CAR T-cell therapy appears safe, effective in advanced Hodgkin lymphoma
August 4, 2020
MedPage Today: Lisa Carey, MD, on Therapy for Early-Stage HER2+ Breast Cancer
July 30, 2020
MedPage Today: CAR-T Safe, Active in Hodgkin Lymphoma
July 28, 2020
Everyday Health: Cancer Survivors More Likely to Develop COVID-19 Infection Despite Precautions
July 25, 2020
ASCO Post: Weathering the Storm: Personal Steps Toward Racial Equity in Oncology
July 24, 2020